Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | EFHD2 |
| Upstream (Parents) |
|---|
| (<<) CD4 → EFHD2 |
| (<<) CFL1 → EFHD2 |
| (<<) GNAI2 → EFHD2 |
| (<<) GSK3A → EFHD2 |
| (<<) HLA-A → EFHD2 |
| (<<) INPP5D → EFHD2 |
| (<<) JAK3 → EFHD2 |
| (<<) KIAA1949 → EFHD2 |
| (<<) PIK3CD → EFHD2 |
| (<<) PLD3 → EFHD2 |
| (<<) PSTPIP1 → EFHD2 |
| (<<) RASSF5 → EFHD2 |
| (<<) RHOG → EFHD2 |
| (<<) SOCS1 → EFHD2 |
| (<<) TGFB1 → EFHD2 |
| (<<) TRAF1 → EFHD2 |
| (<<) YWHAE → EFHD2 |
| Downstream (Children) |
|---|
| EFHD2 → ADCY4 (>>) |
| EFHD2 → BCL3 (>>) |
| EFHD2 → CARD9 (>>) |
| EFHD2 → CASP4 (>>) |
| EFHD2 → COIL (>>) |
| EFHD2 → COTL1 (>>) |
| EFHD2 → CSF2 (>>) |
| EFHD2 → FZD2 (>>) |
| EFHD2 → GNA15 (>>) |
| EFHD2 → GRN (>>) |
| EFHD2 → MAP2K1 (>>) |
| EFHD2 → MAP3K11 (>>) |
| EFHD2 → MKNK2 (>>) |
| EFHD2 → MOBKL2C (>>) |
| EFHD2 → PPP1R11 (>>) |
| EFHD2 → PTK2B (>>) |
| EFHD2 → RPS6KA4 (>>) |
| EFHD2 → RRP15 (>>) |
| EFHD2 → SOX18 (>>) |
| EFHD2 → STAT6 (>>) |
| EFHD2 → TFPI2 (>>) |
| EFHD2 → TNFRSF1A (>>) |
| EFHD2 → ZFPM1 (>>) |
